1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Microsomal Triglyceride Transfer Protein (MTP)

Microsomal Triglyceride Transfer Protein (MTP)

Microsomal triglyceride transfer protein (MTP) is a heterodimer chaperone consisting of a 97-kDa lipid-binding and -transfer subunit and a 55-kDa protein disulfide isomerase (PDI). MTP was first identified as an endoplasmic reticulum (ER) resident protein that helps in the transfer of neutral lipids to nascent apolipoprotein B (apoB). MTP is predominantly expressed in hepatocytes and enterocytes and is required for the assembly and secretion of VLDL and chylomicrons by the liver and intestine, respectivel. Its critical role in the assembly and secretion of apoB-containing lipoproteins was identified in abetalipoproteinemia patients who have mutations in MTP and completely lack apoB-containing lipoproteins in the circulation. It has been established now that MTP not only is involved in the transfer of neutral lipids but also plays a role in cholesterol ester and cluster of differentiation 1d (CD1d) biosynthesis. Besides neutral lipids, MTP may also help in the transfer of sphingolipids such as ceramides and sphingomyelin to the apoB-containing lipoproteins.

Microsomal Triglyceride Transfer Protein (MTP) Related Products (9):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-14668
    Lomitapide mesylate
    99.61%
    Lomitapide mesylate(AEGR-733; BMS-201038) is an inhibitor of microsomal triglyceride-transfer protein (MTP) wtih in vitro IC50 of 8 nM.
    Lomitapide mesylate
  • HY-113955
    CP-346086
    99.16%
    CP-346086 is a potent and orally active microsomal triglyceride transfer protein (MTP) inhibitor, with an IC50 of 2.0 nM for human and rodent MTP. CP-346086 can lower plasma cholesterol and triglycerides in vivo.
    CP-346086
  • HY-106130
    Implitapide
    99.87%
    Implitapide (AEGR 427) is a microsomal triglyceride transfer protein (MTP) inhibitor.
    Implitapide
  • HY-100333
    PF-02575799
    PF-02575799 is a microsomal triglyceride transfer protein (MTP) inhibitor with an IC50 of 0.77±0.29 nM.
    PF-02575799
  • HY-U00070
    Dirlotapide
    ≥99.0%
    Dirlotapide (CP742033) is a gut-selective inhibitor of microsomal triglyceride transfer protein (MTP) that reliably produces weight loss in obese dogs.
    Dirlotapide
  • HY-113955A
    CP-346086 dihydrate
    CP-346086 dihydrate is a potent and orally active microsomal triglyceride transfer protein (MTP) inhibitor, with an IC50 of 2.0 nM for human and rodent MTP. CP-346086 dihydrate can lower plasma cholesterol and triglycerides in vivo.
    CP-346086 dihydrate
  • HY-119220
    Granotapide
    Inhibitor
    Granotapide (JTT-130) is an orally active microsomal triglyceride transfer protein (MTP) inhibitor. Granotapide reduces absorption of cholesterol and triglycerides through inhibition of MTP. Granotapide can be used for the research of dyslipidemia.
    Granotapide
  • HY-U00329
    Implitapide Racemate
    Implitapide Racemate is the racemate of Implitapide. Implitapide is a microsomal triglyceride transfer protein (MTP) inhibitor.
    Implitapide Racemate
  • HY-U00270
    CP-319340(free base)
    CP-319340 free base is a microsomal triglyceride transfer protein (MTP) inhibitor.
    CP-319340(free base)